九州大学大学院医学研究院ウイルス学

柳 雄介 Yanagi Yusuke

経歴

1980 年 九州大学医学部卒業

1980 年 

九州大学医学部附属病院研修医
1981年 九州大学大学院医学研究科内科学 / ウイルス学(柳瀬敏幸教授、森良一教授 )
1981年 カナダ・トロント大学オンタリオ癌研究所ポストドク( Tak W. Mak 教授 )
1985 年 東京大学医学部免疫学助手(多田富雄教授)
1988 年

アメリカ合衆国・スクリプス研究所上級研究員( M.B.A. Oldstone 教授)

1989 年  同研究所助教授
1991 年  東京大学医学部細菌学助手(吉倉廣教授)
1995 年  九州大学医学部ウイルス学教授
2000 年 九州大学大学院医学研究院ウイルス学教授
紹介記事 九大広報 フロントランナー (2007年3月)

 

Original Papers / Reviews

ORIGINAL PAPERS

1: Yanagi Y, Yoshikai Y, Leggett K, Clark SP, Aleksander I, Mak TW.
A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains.
Nature. 1984 Mar 8-14;308(5955):145-9.

2: Siu G, Clark SP, Yoshikai Y, Malissen M, Yanagi Y, Strauss E, Mak TW, Hood L.
The human T cell antigen receptor is encoded by variable, diversity, and joining gene segments that rearrange to generate a complete V gene.
Cell. 1984 Jun;37(2):393-401.

3: Yoshikai Y, Yanagi Y, Suciu-Foca N, Mak TW.
Presence of T-cell receptor mRNA in functionally distinct T cells and elevation during intrathymic differentiation.
Nature. 1984 Aug 9-15;310(5977):506-8.

4: Toyonaga B, Yanagi Y, Suciu-Foca N, Minden M, Mak TW.
Rearrangements of T-cell receptor gene YT35 in human DNA from thymic leukaemia T-cell lines and functional T-cell clones.
Nature. 1984 Sep 27-Oct 3;311(5984):385-7.

5: Yoshikai Y, Anatoniou D, Clark SP, Yanagi Y, Sangster R, Van den Elsen P,Terhorst C, Mak TW.
Sequence and expression of transcripts of the human T-cell receptor beta-chain genes.
Nature. 1984 Dec 6-12;312(5994):521-4.

6: Minden MD, Toyonaga B, Ha K, Yanagi Y, Chin B, Gelfand E, Mak T.
Somatic rearrangement of T-cell antigen receptor gene in human T-cell malignancies.
Proc Natl Acad Sci U S A. 1985 Feb;82(4):1224-7.

7: Yanagi Y, Caccia N, Kronenberg M, Chin B, Roder J, Rohel D, Kiyohara T,Lauzon R, Toyonaga B, Rosenthal K, et al.
Gene rearrangement in cells with natural killer activity and expression of thebeta-chain of the T-cell antigen receptor.
Nature. 1985 Apr 18-24;314(6012):631-3.

8: Yanagi Y, Chan A, Chin B, Minden M, Mak TW.
Analysis of cDNA clones specific for human T cells and the alpha and beta chains of the T-cell receptor heterodimer from a human T-cell line.
Proc Natl Acad Sci U S A. 1985 May;82(10):3430-4.

9: Ohashi PS, Mak TW, Van den Elsen P, Yanagi Y, Yoshikai Y, Calman AF,Terhorst C, Stobo JD, Weiss A.
Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer.
Nature. 1985 Aug 15-21;316(6029):606-9.

10: Okamura H, Yanagi Y, Imari Y, Kudo J, Ishibashi H, Ushijima M, Imamura T.
Werner's syndrome associated with cholangiocarcinoma.
Jpn J Med. 1986 May;25(2):179-83.

11: Yanagi Y, Hirose S, Nagasawa R, Shirai T, Mak TW, Tada T.
Does the deletion within T cell receptor beta-chain gene of NZW mice contribute to autoimmunity in (NZB X NZW)F1 mice?
Eur J Immunol. 1986 Sep;16(9):1179-82.

12: Koga Y, Caccia N, Toyonaga B, Spolski R, Yanagi Y, Yoshikai Y, Mak TW.
A human T cell-specific cDNA clone (YT16) encodes a protein with extensive homology to a family of protein-tyrosine kinases.
Eur J Immunol. 1986 Dec;16(12):1643-6.

13: Takihara Y, Caccia N, Yanagi Y, Mak TW.
Isolation of a T cell specific cDNA clone possibly involved in the T cell activation pathway.
Int Immunol. 1989;1(1):59-65.

14: Furutani M, Yanagi Y, Fujisawa I, Nakayama T, Kishimoto H, Kuida K, Asano Y, Tada T.
Post-transcriptional allelic exclusion of two functionally rearranged T cell receptor alpha genes.
Int Immunol. 1989;1(3):281-8.

15: Nobuhara H, Kuida K, Furutani M, Shiroishi T, Moriwaki K, Yanagi Y, Tada T.
Polymorphism of T-cell receptor genes among laboratory and wild mice: diverse origins of laboratory mice.
Immunogenetics. 1989;30(6):405-13.

16: Nishinarita S, Iizuka Y, Kang H, Kubo N, Sakurada M, Kamei K, Yanagi Y,Akahoshi M, Oshimi K, Sawada S.
CD4/Leu7 and CD8/Leu7 large granular lymphocytosis: comparative studies between NK cells and T cells.
Nippon Ketsueki Gakkai Zasshi. 1989 Sep;52(6):1045-57.

17: Yanagi Y, Maekawa R, Cook T, Kanagawa O, Oldstone MB.
Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
J Virol. 1990 Dec;64(12):5919-26.

18: Yanagi Y, Cubitt BA, Oldstone MB.
Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell.
Virology. 1992 Mar;187(1):280-9.

19: Yanagi Y, Tishon A, Lewicki H, Cubitt BA, Oldstone MB.
Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.
J Virol. 1992 Apr;66(4):2527-31.

20: Horwitz MS, Yanagi Y, Oldstone MB.
T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity.
J Virol. 1994 Jan;68(1):352-7.

21: Yanagi Y, Hu HL, Seya T, Yoshikura H.
Measles virus infects mouse fibroblast cell lines, but its multiplication is severely restricted in the absence of CD46.
Arch Virol. 1994;138(1-2):39-53.

22: Sakae H, Yoshikura H, Yanagi Y.
L cell clone developing plaques upon infection with measles virus (Edmonston strain).
Arch Virol. 1994;139(3-4):427-30.

23: Seya T, Kurita M, Hara T, Iwata K, Semba T, Hatanaka M, Matsumoto M, Yanagi Y, Ueda S, Nagasawa S.
Blocking measles virus infection with a recombinant soluble form of, or
monoclonal antibodies against, membrane cofactor protein of complement (CD46).
Immunology. 1995 Apr;84(4):619-25.

24: Iwata K, Seya T, Yanagi Y, Pesando JM, Johnson PM, Okabe M, Ueda S, Ariga H, Nagasawa S.
Diversity of sites for measles virus binding and for inactivation of complement
C3b and C4b on membrane cofactor protein CD46.
J Biol Chem. 1995 Jun 23;270(25):15148-52.

25: Kurita M, Yanagi Y, Hara T, Nagasawa S, Matsumoto M, Seya T.
Human lymphocytes are more susceptible to measles virus than granulocytes, which is attributable to the phenotypic differences of their membrane cofactor protein (CD46).
Immunol Lett. 1995 Dec;48(2):91-5.

26: Miyagawa S, Ikawa M, Kominami K, Yoshimura Y, Tanaka H, Mikata S, Shirakura R, Matsuda H, Yanagi Y, Seya T, Okabe M.
Difference of expression levels between gene technological product delta CYT-MCP(CD46) and intact MCP(CD46) in transgenic mice.
Transplant Proc. 1996 Apr;28(2):585-6 .

27: Seya T, Kurita M, Iwata K, Yanagi Y, Tanaka K, Shida K, Hatanaka M,Matsumoto M, Jun S, Hirano A, Ueda S, Nagasawa S.
The CD46 transmembrane domain is required for efficient formation of measles-virus-mediated syncytium.
Biochem J. 1997 Feb 15;322 ( Pt 1):135-44 .

28: Tanaka K, Xie M, Yanagi Y.
The hemagglutinin of recent measles virus isolates induces cell fusion in a marmoset cell line, but not in other CD46-positive human and monkey cell lines, when expressed together with the F protein.
Arch Virol. 1998;143(2):213-25.

29: Kimura Y, Hayashida K, Ishibashi H, Niho Y, Akazawa K, Yanagi Y.
Attachment of hepatitis C virus to cultured cells: a novel predictive factor for successful interferon therapy.
J Med Virol. 1998 Sep;56(1):25-32.

30: Pae Y, Minagawa H, Hayashi J, Kashiwagi S, Yanagi Y.
Enhanced IFN-gamma production in vitro by CD8+ T cells in hemophiliacs with AIDS as demonstrated on the single-cell level.
Clin Immunol. 1999 Jul;92(1):111-7.

31: Xie M, Tanaka K, Ono N, Minagawa H, Yanagi Y.
Amino acid substitutions at position 481 differently affect the ability of the measles virus hemagglutinin to induce cell fusion in monkey and marmoset cells co-expressing the fusion protein.
Arch Virol. 1999;144(9):1689-99.

32: Kimura Y, Hayashida K, Ishibashi H, Niho Y, Yanagi Y.
Antibody-free virion titer greatly differs between hepatitis C virus genotypes.
J Med Virol. 2000 May;61(1):37-43.

33: Tatsuo H, Okuma K, Tanaka K, Ono N, Minagawa H, Takade A, Matsuura Y,Yanagi Y.
Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins.
J Virol. 2000 May;74(9):4139-45.

34: Tatsuo H, Ono N, Tanaka K, Yanagi Y.
SLAM (CDw150) is a cellular receptor for measles virus.
Nature. 2000 Aug 24;406(6798):893-7.

35: Kimura Y, Hayashida K, Yanagi Y, Ishibashi H, Akazawa K, Niho Y.
Low cell binding ability of HCV is closely related to interferon treatment especially in patients with HCV genotype 2a/2b. A large series prospective study on Japanese patients with chronic hepatitis C.
J Hepatol. 2000 Nov;33(5):818-25.

36: Minagawa H, Yanagi Y.
Latent herpes simplex virus-1 infection in SCID mice transferred with immune CD4+T cells: a new model for latency.
Arch Virol. 2000;145(11):2259-72.

37: Ono N, Tatsuo H, Tanaka K, Minagawa H, Yanagi Y.
V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor.
J Virol. 2001 Feb;75(4):1594-600.

38: Okuma K, Matsuura Y, Tatsuo H, Inagaki Y, Nakamura M, Yamamoto N, Yanagi Y.
Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins.
J Gen Virol. 2001 Apr;82(Pt 4):821-30.

39: Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, Yanagi Y.
Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor.
J Virol. 2001 May;75(9):4399-401.

40: Tatsuo H, Ono N, Yanagi Y.
Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors.
J Virol. 2001 Jul;75(13):5842-50.

41: Minagawa H, Tanaka K, Ono N, Tatsuo H, Yanagi Y.
Induction of the measles virus receptor SLAM (CD150) on monocytes.
J Gen Virol. 2001 Dec;82(Pt 12):2913-7.

42: Tanaka K, Minagawa H, Xie MF, Yanagi Y.
The measles virus hemagglutinin downregulates the cellular receptor SLAM (CD150).
Arch Virol. 2002;147(1):195-203.

43: Vincent S, Tigaud I, Schneider H, Buchholz CJ, Yanagi Y, Gerlier D.
Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s).
J Virol. 2002 Jun;76(12):6121-30.

44: Hashimoto K, Ono N, Tatsuo H, Minagawa H, Takeda M, Takeuchi K, Yanagi Y.
SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein.
J Virol. 2002 Jul;76(13):6743-9.

45: Bouche FB, Marquet-Blouin E, Yanagi Y, Steinmetz A, Muller CP.
Neutralising immunogenicity of a polyepitope antigen expressed in a transgenic food plant: a novel antigen to protect against measles.
Vaccine. 2003 May 16;21(17-18):2074-81.

46: Shingai M, Ayata M, Ishida H, Matsunaga I, Katayama Y, Seya T, Tatsuo H, Yanagi Y, Ogura H.
Receptor use by vesicular stomatitis virus pseudotypes with glycoproteins of defective variants of measles virus isolated from brains of patients with subacute sclerosing panencephalitis.
J Gen Virol. 2003 Aug;84(Pt 8):2133-43.

47: Ohno S, Seki F, Ono N, Yanagi Y.
Histidine at position 61 and its adjacent amino acid residues are critical for the ability of SLAM (CD150) to act as a cellular receptor for measles virus.
J Gen Virol. 2003 Sep;84(Pt 9):2381-8.

48: Seki F, Ono N, Yamaguchi R, Yanagi Y.
Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells.
J Virol. 2003 Sep;77(18):9943-50.

49:Hashimoto K, Minagawa H, Yanagi Y.
Caspase-dependent apoptosis in fulminant hepatic failure induced by herpes simplex virus in mice.
J Hepatol. 2003 Nov;39(5):773-8.

50:Minagawa H, Hashimoto K, Yanagi Y.
Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections.
J Gen Virol. 2004 Feb;85(Pt 2):343-7.

51:Ishida H, Ayata M, Shingai M, Matsunaga I, Seto Y, Katayama Y, Iritani N, Seya T, Yanagi Y, Matsuoka O,
Yamano T, Ogura H.

Infection of different cell lines of neural origin with subacute sclerosing panencephalitis (SSPE) virus.
Microbiol Immunol. 2004;48(4):277-87.

52:Ohno S, Ono N, Takeda M, Takeuchi K,Yanagi Y.
Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction.
J Gen Virol. 2004 Oct;85(Pt 10):2991-9.

53:Miyajima N, Takeda M, Tashiro M, Hashimoto K, Yanagi Y, Nagata K, Takeuchi K.
Cell tropism of wild-type measles virus is affected by amino acid substitutions in the P, V and M proteins, or by a truncation in the C protein.
J Gen Virol. 2004 Oct;85(Pt 10):3001-6.

54:Davidson D, Shi X, Zhang S, Wang H, Nemer M, Ono N, Ohno S, Yanagi Y,
Veillette A. Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in TH2 cytokine regulation.
Immunity, 2004 Nov;21(5):707-17.

55: Takeda M, Ohno S, Seki F, Hashimoto K, Miyajima N, Takeuchi K, Yanagi Y.
Efficient rescue of measles virus from cloned cDNA using SLAM-expressing Chinese hamster ovary cells.
Virus Res, 2005 Mar;108:161-5

56: Bouche FB, Steinmetz A, Yanagi Y, Muller CP.
Induction of broadly neutralizing antibodies against measles virus mutants using a polyepitope vaccine strategy.
Vaccine 2005 Mar 18;23(17-18):2074-7.

57: Takeda M, Ohno S, Seki F, Nakatsu Y, Tahara M, Yanagi Y.
Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity.
J Virol. 2005 Nov;79(22):14346-54.

58: Tahara M, Takeda M, Yanagi Y.
Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses.
J Virol. 2005 Dec;79(24):15218-25.

59: Takeda M, Nakatsu Y, Ohno S, Seki F, Tahara M, Hashiguchi T, Yanagi Y.
Generation of measles virus with a segmented RNA genome.
J Virol. 2006 May;80(9):4242-8.

60: Seki F, Takeda M, Minagawa H, Yanagi Y.
Recombinant wild-type measles virus containing a single N481Y substitution in its haemagglutinin cannot use receptor CD46 as efficiently as that having the haemagglutinin of the Edmonston laboratory strain.
J Gen Virol. 2006 Jun;87(Pt 6):1643-8.

61: Nakatsu Y, Takeda M, Kidokoro M, Kohara M, Yanagi Y.
Rescue system for measles virus from cloned cDNA driven by vaccinia virus Lister vaccine strain.
J Virol Methods. 2006 Oct;137(1):152-5. Epub 2006 Jul 18.

62:Nakatsu Y, Takeda M, Ohno S, Koga R, Yanagi Y.
Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus.
J Virol. 2006 Dec;80(23):11861-7. Epub 2006 Sep 20.

63:McCausland, M. M., Yusuf, I., Tran, H., Ono, N., Yanagi, Y., and Crotty, S.
SAP regulation of follicular helper CD4 T cell development and humoral immunity is independent of SLAM and Fyn kinase.
J Immunol. 2007, 178:817-28.

64:Ohno, S., Ono, N., Seki, F., Takeda, M., Kura, S., Tsuzuki, T., and Yanagi, Y.
Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection.
J Virol. 2007, 81:1650-9.

65:Tahara, M., Takeda, M., Seki, F., Hashiguchi, T., and Yanagi, Y.
Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently.
J Virol. 2007, 81:2564-72

66:Tahara M, Takeda M, Yanagi Y.
Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion.
J Virol. 2007, 81:6827-36

67:Takeda M, Tahara M, Hashiguchi T, Sato TA, Jinnouchi F, Ueki S, Ohno S, Yanagi Y.
A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism.
J Virol. 2007,81:12091-6.

68:de Swart RL, Ludlow M, de Witte L, Yanagi Y, van Amerongen G, McQuaid S, Yuksel S, Geijtenbeek TB, Duprex WP, Osterhaus AD.
Predominant Infection of CD150(+) Lymphocytes and Dendritic Cells during Measles Virus Infection of Macaques.
PLoS Pathog. 2007, 3(11):e178

69:Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, Sasaki K, Kohda D, Yanagi Y, Maenaka K.
Crystal structure of measles virus hemagglutinin provides insight into effective vaccines.
Proc Natl Acad Sci U S A. 2007

70:Tahara M, Takeda M, Shirogane Y, Hashiguchi T, Ohno S, Yanagi Y.
Measles virus infects both polarized epithelial and immune cells using distinctive receptor-binding sites on its hemagglutinin.
J Virol. 2008 May;82(9):4630-7. Epub 2008 Feb 20.

71:Navaratnarajah CK, Vongpunsawad S, Oezguen N, Stehle T, Braun W, Hashiguchi T, Maenaka K, Yanagi Y, Cattaneo R.
Dynamic interaction of the measles virus hemagglutinin with its receptor SLAM.
J Biol Chem. 2008 Apr 25;283(17):11763-71. Epub 2008 Feb 21.

72:Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, Sasaki K, Kohda D, Yanagi Y, Maenaka K.
Homogeneous sugar modification improves crystallization of measles virus hemagglutinin.
J Virol Methods. 2008 Apr;149(1):171-4. Epub 2008 Mar 4

73:Shirogane, Y., Takeda, M., Iwasaki, M., Ishiguro, N., Takeuchi, H., Nakatsu, Y., Tahara, M., Kikuta, H., and Yanagi, Y.
(2008) Efficient Multiplication of Human Metapneumovirus in Vero Cells Expressing the Transmembrane Serine Protease TMPRSS2.
J Virol. 82. 8942-6.

74:Nakatsu, Y., Takeda, M., Ohno, S., Shirogane, Y., Iwasaki, M., and Yanagi, Y.
(2008) Measles virus circumvents the host interferon response by different actions of the C and V proteins.
J Virol. 82. 8296-306.

75: Takeda M, Ohno S, Tahara M, Takeuchi H, Shirogane Y, Ohmura H, Nakamura T, Yanagi Y.
Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice.
J Virol. 2008, 82:11979-84.

76: Iwasaki M, Takeda M, Shirogane Y, Nakatsu Y, Nakamura T, Yanagi Y.
The Matrix Protein of Measles Virus Regulates Viral RNA Synthesis and Assembly by Interacting with the Nucleocapsid Protein.
J Virol. 2009, 83:10374-83.

77: Yasukawa K, Oshiumi H, Takeda M, Ishihara N, Yanagi Y, Seya T, Kawabata S, Koshiba T.
Mitofusin 2 Inhibits Mitochondrial Antiviral Signaling
Sci Signal, 2009, 2:ra47.

78: Nakatsu Y, Takeda M, Iwasaki M, Yanagi Y.
A Highly Attenuated Measles Virus Vaccine Strain Encodes a Fully Functional
C Protein
J Virol. 2009, 83:11996-2001.

79: Ikegame S, Takeda M, Ohno S, Nakatsu Y, Nakanishi Y, Yanagi Y.
Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells.
J Virol. 2010, 84:372-9.

80: Meng X, Nakamura T, Okazaki T, Inoue H, Takahashi A, Miyamoto S, Sakaguchi G, Eto M, Naito S, Takeda M, Yanagi Y, Tani K.
Enhanced antitumor effects of an engineered measles virus Edmonston strain expressing the wild-type N, P, L genes on human renal cell carcinoma.
Mol Ther. 2010, 18:544-51.

81: Koga R, Ohno S, Ikegame S, Yanagi Y
Measles Virus-Induced Immunosuppression in SLAM Knock-In Mice.
J Virol. 2010, 84:5360-7.

82: Shirogane Y, Takeda M, Tahara M, Ikegame S, Nakamura T, Yanagi Y.
Epithelial-mesenchymal transition abolishes the susceptibility of polarized epithelial cell lines to measles virus.
J Biol Chem. 2010, 285:20882-90.

83: Hashiguchi T, Ose T, Kubota M, Maita N, Kamishikiryo J, Maenaka K, Yanagi Y.
Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM.
Nat Struct Mol Biol. 2011 Feb;18(2):135-41.

84: Koshiba T, Yasukawa K, Yanagi Y, Kawabata S.
Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling
Sci Signal. 2011 Feb 1;4(158):ra7.

最新の論文は主要発表論文の項目を参照のこと

ページの先頭へ

 

REVIEWS

1: Mak TW, Yanagi Y.
Genes encoding the human T cell antigen receptor.
Immunol Rev. 1984 Oct;81:221-33. Review.

2: Yanagi Y.
[The T-cell antigen receptor and T-cell antigen recognition]
Seikagaku. 1988 Feb;60(2):75-88. Review. Japanese.

3: Yanagi Y.
T-cell receptor and T-cell-resistant virus variants.
Curr Opin Immunol. 1991 Aug;3(4):460-4. Review.

4: Yanagi Y.
[Measles virus infection and immunosuppression]
Uirusu. 1995 Dec;45(2):117-23. Review. Japanese.

5: Yanagi Y.
[Measles virus receptor CD46]
Uirusu. 1995 Dec;45(2):159-64. Review. Japanese.

6: Okuma K, Yanagi Y.
[Approach to the identification of virus receptor]
Uirusu. 1999 Jun;49(1):1-9. Review. Japanese.

7: Tatsuo H, Ono N, Tanaka K, Yanagi Y.
[The cellular receptor for measles virus: SLAM (CDw 150)]
Uirusu. 2000 Dec;50(2):289-96. Review. Japanese.

8: Yanagi Y.
The cellular receptor for measles virus--elusive no more.
Rev Med Virol. 2001 May-Jun;11(3):149-56. Review.

9: Yanagi Y.
[The cellular receptor for measles virus]
Uirusu. 2001 Dec;51(2):201-8. Review. Japanese.

10: Tatsuo H, Yanagi Y.
The morbillivirus receptor SLAM (CD150).
Microbiol Immunol. 2002;46(3):135-42. Review.

11: Hashimoto K, Yanagi Y.
[Measles virus entry as examined by a recombinant virus expressing green
fluorescent protein]
Uirusu. 2002 Jun;52(1):169-75. Review. Japanese.

12: Yanagi Y, Ono N, Tatsuo H, Hashimoto K, Minagawa H.
Measles virus receptor SLAM (CD150).
Virology. 2002 Aug 1;299(2):155-61. Review.

13: Yanagi Y, Takeda M, Ohno S, Seki F.
Measles virus receptors and tropism.
Jpn J Infect Dis. 2006 Feb;59(1):1-5. Review.

14:Takeda M, Yanagi Y.
[Reverse genetics for measles virus]
Fukuoka Igaku Zasshi. 2006 May;97(5):140-5. Review. Japanese.

15:Yanagi Y, Takeda M, Ohno S.
Measles virus: cellular receptors, tropism and pathogenesis.
J Gen Virol. 2006 Oct;87(Pt 10):2767-79. Review.

16:Ohno S, Yanagi Y.
[Cellular tropism and adaptation of the measles virus]
Uirusu. 2006 Jun;56(1):27-34. Review. Japanese.

17:Yanagi Y, Takeda M, Ohno S.
[Measles virus entry and cellular receptors]
Tanpakushitsu Kakusan Koso. 2007, 52(10 Suppl):1088-94. Review. Japanese.

18: Nakatsu Y, Yanagi Y.
[Evasion of host type I IFN response by measles virus]
Fukuoka Igaku Zasshi. 2008, 99:144-9. Review. Japanese.

19: Hashiguchi T, Maenaka K, Yanagi Y.
X-ray crystallographic analysis of measles virus hemagglutinin.
Uirusu. 2008, 58:1-10. Review. Japanese.

20: Yanagi Y, Takeda M, Ohno S, Hashiguchi T.
Measles virus receptors
Curr Top Microbiol Immunol. 2009;329:13-30. Review

最新の論文は主要発表論文の項目を参照のこと

ページの先頭へ

English お問い合わせ 九州大学大学院医学研究院ウイルス学